279 related articles for article (PubMed ID: 35202480)
1. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis.
Dunleavy C; Elsworthy RJ; Upthegrove R; Wood SJ; Aldred S
Acta Psychiatr Scand; 2022 Jul; 146(1):6-20. PubMed ID: 35202480
[TBL] [Abstract][Full Text] [Related]
2. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.
Upthegrove R; Manzanares-Teson N; Barnes NM
Schizophr Res; 2014 May; 155(1-3):101-8. PubMed ID: 24704219
[TBL] [Abstract][Full Text] [Related]
3. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
[TBL] [Abstract][Full Text] [Related]
5. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder.
Hughes HK; Yang H; Lesh TA; Carter CS; Ashwood P
J Neuroinflammation; 2022 Dec; 19(1):287. PubMed ID: 36463221
[TBL] [Abstract][Full Text] [Related]
6. Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.
Noto C; Ota VK; Gouvea ES; Rizzo LB; Spindola LM; Honda PH; Cordeiro Q; Belangero SI; Bressan RA; Gadelha A; Maes M; Brietzke E
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522386
[TBL] [Abstract][Full Text] [Related]
7. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis.
Noto MN; Maes M; Nunes SOV; Ota VK; Rossaneis AC; Verri WA; Cordeiro Q; Belangero SI; Gadelha A; Bressan RA; Noto C
Eur Neuropsychopharmacol; 2019 Mar; 29(3):416-431. PubMed ID: 30594344
[TBL] [Abstract][Full Text] [Related]
8. Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.
Noto C; Ota VK; Santoro ML; Gouvea ES; Silva PN; Spindola LM; Cordeiro Q; Bressan RA; Gadelha A; Brietzke E; Belangero SI; Maes M
Mol Neurobiol; 2016 Oct; 53(8):5701-9. PubMed ID: 26491028
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Miller BJ; Buckley P; Seabolt W; Mellor A; Kirkpatrick B
Biol Psychiatry; 2011 Oct; 70(7):663-71. PubMed ID: 21641581
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis.
Capuzzi E; Bartoli F; Crocamo C; Clerici M; Carrà G
Neurosci Biobehav Rev; 2017 Jun; 77():122-128. PubMed ID: 28285148
[TBL] [Abstract][Full Text] [Related]
12. Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.
Mondelli V; Ciufolini S; Belvederi Murri M; Bonaccorso S; Di Forti M; Giordano A; Marques TR; Zunszain PA; Morgan C; Murray RM; Pariante CM; Dazzan P
Schizophr Bull; 2015 Sep; 41(5):1162-70. PubMed ID: 25829375
[TBL] [Abstract][Full Text] [Related]
13. Peripheral immune markers and antipsychotic non-response in psychosis.
Enache D; Nikkheslat N; Fathalla D; Morgan BP; Lewis S; Drake R; Deakin B; Walters J; Lawrie SM; Egerton A; MacCabe JH; Mondelli V
Schizophr Res; 2021 Apr; 230():1-8. PubMed ID: 33667853
[TBL] [Abstract][Full Text] [Related]
14. Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis.
Zhang T; Zeng J; Wei Y; Ye J; Tang X; Xu L; Hu Y; Liu H; Chen T; Li C; Wang J
Neuropsychobiology; 2023; 82(2):104-116. PubMed ID: 36796338
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.
Corsi-Zuelli F; Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Louzada-Junior P; Mondelli V; Del-Ben CM
Psychol Med; 2020 May; 50(7):1139-1147. PubMed ID: 31064423
[TBL] [Abstract][Full Text] [Related]
17. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
Kelsven S; de la Fuente-Sandoval C; Achim CL; Reyes-Madrigal F; Mirzakhanian H; Domingues I; Cadenhead K
Schizophr Res; 2020 Dec; 226():13-23. PubMed ID: 32089474
[TBL] [Abstract][Full Text] [Related]
18. Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studies.
Cadenhead KS; Mirzakhanian H; Achim C; Reyes-Madrigal F; de la Fuente-Sandoval C
Schizophr Res; 2024 Feb; 264():39-48. PubMed ID: 38091871
[TBL] [Abstract][Full Text] [Related]
19. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study.
Balõtšev R; Haring L; Koido K; Leping V; Kriisa K; Zilmer M; Vasar V; Piir A; Lang A; Vasar E
Early Interv Psychiatry; 2019 Feb; 13(1):101-109. PubMed ID: 28719155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
